Endometrial Neoplasms[Mesh] - Search Results

Year	Number of Results
1947	1
1949	1
1951	1
1953	1
1959	1
1960	1
1964	1
1991	5
1992	14
1993	23
1994	30
1995	51
1996	56
1997	57
1998	60
1999	62
2000	60
2001	69
2002	101
2003	82
2004	105
2005	135
2006	150
2007	171
2008	228
2009	249
2010	277
2011	303
2012	326
2013	376
2014	413
2015	475
2016	533
2017	434
2018	481
2019	582
2020	587
2021	674
2022	754
2023	699
2024	213

1

Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.

Qiu J, Zhao Z, Suo H, Paraghamian SE, Hawkins GM, Sun W, Zhang X, Hao T, Deng B, Shen X, Zhou C, Bae-Jump V. Qiu J, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2325130. doi: 10.1080/15384047.2024.2325130. Epub 2024 Mar 11. Cancer Biol Ther. 2024. PMID: 38465855 Free PMC article.

2

Barriers and facilitators for healthy lifestyle and recommendations for counseling in endometrial cancer follow-up care: a qualitative study.

de Korte AM, de Rooij BH, Boll D, van Loon I, Vincent N, Hoedjes M, Lammens CRM, Mols F, van der Lee ML, Vos MC, Ezendam NPM. de Korte AM, et al. J Psychosom Obstet Gynaecol. 2024 Dec;45(1):2340465. doi: 10.1080/0167482X.2024.2340465. Epub 2024 Apr 15. J Psychosom Obstet Gynaecol. 2024. PMID: 38622864 Free article.

3

Causal relationship between affect disorders and endometrial cancer: a Mendelian randomisation study.

Sun Y, Geng S, Fu C, Song X, Lin H, Xu Y. Sun Y, et al. J Obstet Gynaecol. 2024 Dec;44(1):2321321. doi: 10.1080/01443615.2024.2321321. Epub 2024 Feb 29. J Obstet Gynaecol. 2024. PMID: 38425012 Free article.

4

GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death.

Li W, Lyu W, Liu S, Ruan F, Zhang X. Li W, et al. J Obstet Gynaecol. 2024 Dec;44(1):2301324. doi: 10.1080/01443615.2023.2301324. Epub 2024 Jan 25. J Obstet Gynaecol. 2024. PMID: 38269495 Free article.

5

Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?

Vrede SW, Donkers H, Reijnen C, Smits A, Visser NCM, Geomini PM, Ngo H, van Hamont D, Pijlman BM, Vos MC, Snijders MPLM, Kruitwagen R, Bekkers RLM, Galaal K, Pijnenborg JMA. Vrede SW, et al. J Obstet Gynaecol. 2024 Dec;44(1):2294332. doi: 10.1080/01443615.2023.2294332. Epub 2024 Jan 7. J Obstet Gynaecol. 2024. PMID: 38186008 Free article.

6

The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: a systematic review and meta-analysis.

Ogunbiyi MO, Oxley S, Graham R, Olaitan A. Ogunbiyi MO, et al. J Obstet Gynaecol. 2024 Dec;44(1):2294329. doi: 10.1080/01443615.2023.2294329. Epub 2023 Dec 21. J Obstet Gynaecol. 2024. PMID: 38126736 Free article. Review.

7

Leptin secreted by adipocytes promotes EMT transition and endometrial cancer progression via the JAK2/STAT3 signalling pathway.

Shen L, Zhang C, Cui K, Liang X, Zhu G, Hong L. Shen L, et al. Adipocyte. 2024 Dec;13(1):2293273. doi: 10.1080/21623945.2023.2293273. Epub 2023 Dec 13. Adipocyte. 2024. PMID: 38090745 Free PMC article.

8

A selective anatomically based lymph node sampling can replace a side specific pelvic lymphadenectomy in endometrial cancer with failed sentinel node mapping.

Bollino M, Geppert B, Lönnerfors C, Persson J. Bollino M, et al. Eur J Cancer. 2024 Jun;204:114049. doi: 10.1016/j.ejca.2024.114049. Epub 2024 Apr 12. Eur J Cancer. 2024. PMID: 38657525 Free article.

9

Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq.

Mo WJ, Liang ZQ, Huang JZ, Huang ZG, Zhi ZF, Chen JH, Chen G, Zeng JJ, Feng ZB. Mo WJ, et al. Int J Biol Markers. 2024 Jun;39(2):168-183. doi: 10.1177/03936155241238759. Epub 2024 Apr 22. Int J Biol Markers. 2024. PMID: 38646803 Free article.

10

FIGO 2023 endometrial staging: a leap of faith into the new "prognostic based' rather than "anatomical based" staging-too fast too furious??

Bassetty KC, Begum D, Barmon D, Baruah U, Gupta S, Kumar M, Nath J, Khanikar D, Bhattacharyya M, Roy PS. Bassetty KC, et al. J Cancer Res Clin Oncol. 2024 May 11;150(5):251. doi: 10.1007/s00432-024-05739-w. J Cancer Res Clin Oncol. 2024. PMID: 38733417 Free PMC article.

11

VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology.

Nakhli R, Rich K, Zhang A, Darbandsari A, Shenasa E, Hadjifaradji A, Thiessen S, Milne K, Jones SJM, McAlpine JN, Nelson BH, Gilks CB, Farahani H, Bashashati A. Nakhli R, et al. Nat Commun. 2024 May 10;15(1):3942. doi: 10.1038/s41467-024-48062-1. Nat Commun. 2024. PMID: 38729933 Free PMC article.

12

Association between immune cells and endometrial cancer: A bidirectional Mendelian randomization study.

Zou X, Shen J, Zhang H, Kong F, Jin X, Zhang L. Zou X, et al. Medicine (Baltimore). 2024 May 10;103(19):e38129. doi: 10.1097/MD.0000000000038129. Medicine (Baltimore). 2024. PMID: 38728458 Free PMC article.

13

Weibull parametric model for survival analysis in women with endometrial cancer using clinical and T2-weighted MRI radiomic features.

Li X, Marcus D, Russell J, Aboagye EO, Ellis LB, Sheeka A, Park WE, Bharwani N, Ghaem-Maghami S, Rockall AG. Li X, et al. BMC Med Res Methodol. 2024 May 9;24(1):107. doi: 10.1186/s12874-024-02234-1. BMC Med Res Methodol. 2024. PMID: 38724889 Free PMC article.

14

Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.

Lin X, Zheng J, Cai X, Liu L, Jiang S, Liu Q, Sun Y. Lin X, et al. BMC Cancer. 2024 May 8;24(1):571. doi: 10.1186/s12885-024-12327-1. BMC Cancer. 2024. PMID: 38720279 Free PMC article.

15

Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.

Lin Y, Chen X, Lin L, Xu B, Zhu X, Lin X. Lin Y, et al. Cell Mol Biol Lett. 2024 May 2;29(1):63. doi: 10.1186/s11658-024-00583-9. Cell Mol Biol Lett. 2024. PMID: 38698330 Free PMC article.

16

Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.

Pagán Santana Y, Castañeda Ávila M, Ríos Motta R, Ortiz Ortiz KJ. Pagán Santana Y, et al. PLoS One. 2024 May 2;19(5):e0302253. doi: 10.1371/journal.pone.0302253. eCollection 2024. PLoS One. 2024. PMID: 38696411 Free PMC article.

17

Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.

Linder A, Westbom-Fremer S, Mateoiu C, Olsson Widjaja A, Österlund T, Veerla S, Ståhlberg A, Ulfenborg B, Hedenfalk I, Sundfeldt K. Linder A, et al. Hum Reprod. 2024 May 2;39(5):1141-1154. doi: 10.1093/humrep/deae043. Hum Reprod. 2024. PMID: 38459814 Free PMC article.

18

Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer.

Parulekar M, Kim H, Kim K, Ala A. Parulekar M, et al. J Gynecol Oncol. 2024 May;35(3):e94. doi: 10.3802/jgo.2024.35.e94. J Gynecol Oncol. 2024. PMID: 38764327 Free article. No abstract available.

19

Validating the 2023 FIGO staging system: A nomogram for endometrioid endometrial cancer and adenocarcinoma.

Feng Y, Miao F, Li Y, Li M, Cao Y. Feng Y, et al. Cancer Med. 2024 May;13(10):e7216. doi: 10.1002/cam4.7216. Cancer Med. 2024. PMID: 38752451 Free PMC article.

20

Endometrial cancer: improving management among increasing incidence rates.

eBioMedicine. eBioMedicine. EBioMedicine. 2024 May;103:105159. doi: 10.1016/j.ebiom.2024.105159. EBioMedicine. 2024. PMID: 38749574 Free article. No abstract available.

21

ARID1 and BRG1 Expression in Endometrial Cancer.

Kontomanolis EN, Symeonidis P, Nikolettos K, Perros P, Rody A, Tsikouras P, Nikolettos N, Giatromanolaki A. Kontomanolis EN, et al. In Vivo. 2024 May-Jun;38(3):1260-1265. doi: 10.21873/invivo.13563. In Vivo. 2024. PMID: 38688602 Free PMC article.

22

Response to: Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.

Akgor U, Ozgul N, Ayhan A. Akgor U, et al. J Gynecol Oncol. 2024 May;35(3):e92. doi: 10.3802/jgo.2024.35.e92. Epub 2024 Apr 11. J Gynecol Oncol. 2024. PMID: 38616118 Free article. No abstract available.

23

Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.

Akgor U. Akgor U. J Gynecol Oncol. 2024 May;35(3):e89. doi: 10.3802/jgo.2024.35.e89. Epub 2024 Apr 1. J Gynecol Oncol. 2024. PMID: 38606829 Free article. No abstract available.

24

Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer.

Lee YY, Chen YL, Lai YL. Lee YY, et al. J Gynecol Oncol. 2024 May;35(3):e88. doi: 10.3802/jgo.2024.35.e88. Epub 2024 Apr 1. J Gynecol Oncol. 2024. PMID: 38606828 Free article. No abstract available.

25

Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)? A systematic review and meta-analysis.

Sun Y, Lin S, Wu W, Nie F, Liu Y, Wen J, Cheng X, Liu Q, Wang Y, Ren F. Sun Y, et al. Int J Surg. 2024 May 1;110(5):3072-3080. doi: 10.1097/JS9.0000000000001234. Int J Surg. 2024. PMID: 38445439 Free PMC article.

26

Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.

Kato MK, Fujii E, Asami Y, Momozawa Y, Hiranuma K, Komatsu M, Hamamoto R, Ebata T, Matsumoto K, Ishikawa M, Kohno T, Kato T, Yoshida H, Shiraishi K. Kato MK, et al. Cancer Sci. 2024 May;115(5):1646-1655. doi: 10.1111/cas.16121. Epub 2024 Mar 3. Cancer Sci. 2024. PMID: 38433331 Free PMC article.

27

Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial Cancer: Analysis of 124 Lymph Nodes.

Huber D, Hurni Y. Huber D, et al. J Minim Invasive Gynecol. 2024 May;31(5):438-444. doi: 10.1016/j.jmig.2024.02.007. Epub 2024 Feb 29. J Minim Invasive Gynecol. 2024. PMID: 38428574 Free article.

28

Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.

Goetz LH, Evans HL, Armylagos D, Zhou H, Mody DR, Schwartz MR, Ge Y. Goetz LH, et al. J Am Soc Cytopathol. 2024 May-Jun;13(3):227-232. doi: 10.1016/j.jasc.2024.01.004. Epub 2024 Jan 29. J Am Soc Cytopathol. 2024. PMID: 38401997 Free article.

29

A case report of endometrial stromal sarcoma with sex-cord differentiation.

Wang H, Xie Y. Wang H, et al. Asian J Surg. 2024 May;47(5):2308-2309. doi: 10.1016/j.asjsur.2024.01.165. Epub 2024 Feb 7. Asian J Surg. 2024. PMID: 38331613 Free article. No abstract available.

30

Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.

Lv X, Guo L, Wang C. Lv X, et al. J Gynecol Oncol. 2024 May;35(3):e27. doi: 10.3802/jgo.2024.35.e27. Epub 2023 Dec 18. J Gynecol Oncol. 2024. PMID: 38216133 Free PMC article.

31

Lymphedema self-assessment among endometrial cancer survivors.

Brown JA, Olshan AF, Bae-Jump VL, Ogunleye AA, Smith S, Black-Grant S, Nichols HB. Brown JA, et al. Cancer Causes Control. 2024 May;35(5):771-785. doi: 10.1007/s10552-023-01838-0. Epub 2024 Jan 4. Cancer Causes Control. 2024. PMID: 38175324 Free PMC article.

32

Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan.

Lee YY, Lai YL, Kim MS, Chang K, Kim HS, Cheng WF, Chen YL. Lee YY, et al. J Gynecol Oncol. 2024 May;35(3):e33. doi: 10.3802/jgo.2024.35.e33. Epub 2023 Dec 12. J Gynecol Oncol. 2024. PMID: 38130137 Free PMC article.

33

Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.

Shim SH, Lim J, Kim JH, Lee YJ, Ha HI, Lim MC, Won YJ. Shim SH, et al. J Gynecol Oncol. 2024 May;35(3):e32. doi: 10.3802/jgo.2024.35.e32. Epub 2023 Dec 19. J Gynecol Oncol. 2024. PMID: 38130136 Free PMC article.

34

Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.

Lee Y, Choi S, Kim HS. Lee Y, et al. Int J Gynecol Pathol. 2024 May 1;43(3):221-232. doi: 10.1097/PGP.0000000000000976. Epub 2023 Aug 11. Int J Gynecol Pathol. 2024. PMID: 37566876 Free PMC article.

35

Analysis of CDO1, PITX2, and CDH13 Gene Methylation in Early Endometrial Cancer for Prediction of Medical Treatment Outcomes.

Krasnyi AM, Gadzhieva LT, Kokoeva DN, Kosenko MG, Yarotskaya EL, Pavlovich SV, Ashrafyan LA, Sukhikh GT. Krasnyi AM, et al. Int J Mol Sci. 2024 Apr 30;25(9):4892. doi: 10.3390/ijms25094892. Int J Mol Sci. 2024. PMID: 38732110 Free PMC article.

36

Diabetes and the social, biologic, and behavioral determinants of endometrial cancer in the United States.

Massouh N, Jaffa AA, Jaffa MA. Massouh N, et al. BMC Cancer. 2024 Apr 29;24(1):540. doi: 10.1186/s12885-024-12192-y. BMC Cancer. 2024. PMID: 38684955 Free PMC article.

37

Factors associated with interobserver variation amongst pathologists in the diagnosis of endometrial hyperplasia: A systematic review.

McCoy CA, Coleman HG, McShane CM, McCluggage WG, Wylie J, Quinn D, McMenamin ÚC. McCoy CA, et al. PLoS One. 2024 Apr 29;19(4):e0302252. doi: 10.1371/journal.pone.0302252. eCollection 2024. PLoS One. 2024. PMID: 38683770 Free PMC article.

38

The KRAS, ATR and CHEK1 expression levels in endometrial cancer are the risk factors predicting recurrence.

Buchynska L, Gordiienko I, Glushchenko N, Iurchenko N. Buchynska L, et al. PLoS One. 2024 Apr 26;19(4):e0302075. doi: 10.1371/journal.pone.0302075. eCollection 2024. PLoS One. 2024. PMID: 38669256 Free PMC article.

39

The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer.

Capaci V, Kharrat F, Conti A, Salviati E, Basilicata MG, Campiglia P, Balasan N, Licastro D, Caponnetto F, Beltrami AP, Monasta L, Romano F, Di Lorenzo G, Ricci G, Ura B. Capaci V, et al. Int J Mol Sci. 2024 Apr 24;25(9):4650. doi: 10.3390/ijms25094650. Int J Mol Sci. 2024. PMID: 38731868 Free PMC article.

40

Refractory Pneumothorax Due to Cystic Pulmonary Metastasis of a Lowgrade Endometrial Stromal Sarcoma: A Case Report.

Watanabe H, Nakagawa T, Masuda R, Yamada S, Iwazaki M. Watanabe H, et al. Tokai J Exp Clin Med. 2024 Apr 20;49(1):31-34. Tokai J Exp Clin Med. 2024. PMID: 38509011 Free article.

41

Development of a long term, ex vivo, patient-derived explant model of endometrial cancer.

van der Woude H, Phan K, Kenwright DN, Goossens L, Hally KE, Currie MJ, Kokkinos J, Sharbeen G, Phillips PA, Henry CE. van der Woude H, et al. PLoS One. 2024 Apr 18;19(4):e0301413. doi: 10.1371/journal.pone.0301413. eCollection 2024. PLoS One. 2024. PMID: 38635728 Free PMC article.

42

Associations between transport modes and site-specific cancers: a systematic review and meta-analysis.

Thu W, Woodward A, Cavadino A, Tin Tin S. Thu W, et al. Environ Health. 2024 Apr 13;23(1):39. doi: 10.1186/s12940-024-01081-3. Environ Health. 2024. PMID: 38609941 Free PMC article. Review.

43

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study.

Zhang L, Yan H. Zhang L, et al. Sci Rep. 2024 Apr 10;14(1):8382. doi: 10.1038/s41598-024-58950-7. Sci Rep. 2024. PMID: 38600147 Free PMC article.

44

Risk assessment of extra-uterine involvement and prognosis in young type I endometrial carcinoma with high or moderate differentiation and less than 1/2 myometrial invasion.

Sun Y, Han P, Wang Y, Cheng X, Wu W, Liu Q, Ren F. Sun Y, et al. Aging (Albany NY). 2024 Apr 3;16(7):6445-6454. doi: 10.18632/aging.205714. Epub 2024 Apr 3. Aging (Albany NY). 2024. PMID: 38575312 Free PMC article.

45

Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study.

Shehaj I, Krajnak S, Rad MT, Gasimli B, Hasenburg A, Karn T, Schmidt M, Müller V, Becker S, Gasimli K. Shehaj I, et al. J Cancer Res Clin Oncol. 2024 Apr 3;150(4):174. doi: 10.1007/s00432-024-05699-1. J Cancer Res Clin Oncol. 2024. PMID: 38570343 Free PMC article.

46

Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe.

Zhang J, Kelkar SS, Prabhu VS, Qiao Y, Grall V, Miles N, Marth C. Zhang J, et al. BMJ Open. 2024 Apr 2;14(4):e079447. doi: 10.1136/bmjopen-2023-079447. BMJ Open. 2024. PMID: 38569701 Free PMC article.

47

Rate and risk factors of inadequate endometrial tissues after endometrial sampling among Bhutanese women at the national referral hospital of Bhutan: a cross-sectional study.

Dorji N, Dorjey Y, Tshering S, Pradhan B, Chhetri M, Bhujel D. Dorji N, et al. BMC Womens Health. 2024 Apr 2;24(1):214. doi: 10.1186/s12905-024-03047-6. BMC Womens Health. 2024. PMID: 38566186 Free PMC article.

48

Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers.

Bukato K, Kostrzewa T, Gammazza AM, Gorska-Ponikowska M, Sawicki S. Bukato K, et al. Cell Commun Signal. 2024 Apr 2;22(1):205. doi: 10.1186/s12964-024-01583-0. Cell Commun Signal. 2024. PMID: 38566107 Free PMC article. Review.

49

LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination.

Wang B, Wang B, Ma J, He JJ, Wang ZH, Li Q, Ma XX. Wang B, et al. Cell Death Dis. 2024 Apr 2;15(4):242. doi: 10.1038/s41419-024-06564-2. Cell Death Dis. 2024. PMID: 38565547 Free PMC article.

50

Histological assessment of endometrial polyps resected by hysteroscopy.

Tekin S, Ocal A, Sisman E, Bilginer C, Cetin A. Tekin S, et al. Eur Rev Med Pharmacol Sci. 2024 Apr;28(8):3241-3250. doi: 10.26355/eurrev_202404_36052. Eur Rev Med Pharmacol Sci. 2024. PMID: 38708482 Free article.

51

Clinicopathological Pattern of Endometrial Specimens in Women with Abnormal Uterine Bleeding and Ultrasonography Correlation.

Karimi M, Alizadeh A, Mahmoodi M. Karimi M, et al. Arch Iran Med. 2024 Apr 1;27(4):216-222. doi: 10.34172/aim.2024.31. Arch Iran Med. 2024. PMID: 38685848 Free PMC article.

52

PD-L1 Immunohistochemical Expression in Endometrial Carcinoma: Egyptian Cross-Sectional Study.

Wahba MG, Soliman SS, Salama ME, Nasr S, Al Shereef ZAE. Wahba MG, et al. Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1441-1450. doi: 10.31557/APJCP.2024.25.4.1441. Asian Pac J Cancer Prev. 2024. PMID: 38680006 Free article.

53

Integrated single-cell RNA sequencing and spatial transcriptomics analysis reveals the tumour microenvironment in patients with endometrial cancer responding to anti-PD-1 treatment.

Chen J, Song Y, Huang J, Wan X, Li Y. Chen J, et al. Clin Transl Med. 2024 Apr;14(4):e1668. doi: 10.1002/ctm2.1668. Clin Transl Med. 2024. PMID: 38649737 Free PMC article. No abstract available.

54

Immune checkpoint inhibitors alone or in combination for endometrial mismatch repair-deficient/MSI-high population.

Canario R, Colombo N, Joly F. Canario R, et al. ESMO Open. 2024 Apr;9(4):102984. doi: 10.1016/j.esmoop.2024.102984. Epub 2024 Apr 12. ESMO Open. 2024. PMID: 38613912 Free PMC article. No abstract available.

55

Predicting Response to Immunotargeted Therapy in Endometrial Cancer via Tumor Immune Microenvironment: A Multicenter, Observational Study.

Maltseva A, Kalinchuk A, Chernorubashkina N, Sisakyan V, Lots I, Gofman A, Anzhiganova Y, Martynova E, Zukov R, Aleksandrova E, Kolomiets L, Tashireva L. Maltseva A, et al. Int J Mol Sci. 2024 Apr 1;25(7):3933. doi: 10.3390/ijms25073933. Int J Mol Sci. 2024. PMID: 38612743 Free PMC article.

56

Detection of endometrial cancer in cervico-vaginal fluid and blood plasma: leveraging proteomics and machine learning for biomarker discovery.

Njoku K, Pierce A, Chiasserini D, Geary B, Campbell AE, Kelsall J, Reed R, Geifman N, Whetton AD, Crosbie EJ. Njoku K, et al. EBioMedicine. 2024 Apr;102:105064. doi: 10.1016/j.ebiom.2024.105064. Epub 2024 Mar 20. EBioMedicine. 2024. PMID: 38513301 Free PMC article.

57

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis.

Bartoletti M, Montico M, Lorusso D, Mazzeo R, Oaknin A, Musacchio L, Scambia G, Puglisi F, Pignata S. Bartoletti M, et al. Cancer Treat Rev. 2024 Apr;125:102701. doi: 10.1016/j.ctrv.2024.102701. Epub 2024 Feb 27. Cancer Treat Rev. 2024. PMID: 38422895 Free article. Review.

58

Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients.

Meril S, Muhlbauer Avni M, Lior C, Bahlsen M, Olender T, Savidor A, Krausz J, Belhanes Peled H, Birisi H, David N, Bialik S, Scherz-Shouval R, Ben David Y, Kimchi A. Meril S, et al. Oncogene. 2024 Apr;43(15):1098-1112. doi: 10.1038/s41388-024-02981-x. Epub 2024 Feb 22. Oncogene. 2024. PMID: 38388710 Free PMC article.

59

Identification and validation of serum metabolite biomarkers for endometrial cancer diagnosis.

Liu W, Ma J, Zhang J, Cao J, Hu X, Huang Y, Wang R, Wu J, Di W, Qian K, Yin X. Liu W, et al. EMBO Mol Med. 2024 Apr;16(4):988-1003. doi: 10.1038/s44321-024-00033-1. Epub 2024 Feb 14. EMBO Mol Med. 2024. PMID: 38355748 Free PMC article.

60

The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade: A retrospective study in a single center, South Korea.

Jang S, Hwang SO. Jang S, et al. Eur J Obstet Gynecol Reprod Biol. 2024 Apr;295:118-123. doi: 10.1016/j.ejogrb.2024.01.033. Epub 2024 Jan 28. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38354603 Free article.

61

Targeting GRP75 with a Chlorpromazine Derivative Inhibits Endometrial Cancer Progression Through GRP75-IP3R-Ca²⁺-AMPK Axis.

Wang Q, Li L, Gao X, Zhang C, Xu C, Song L, Li J, Sun X, Mao F, Wang Y. Wang Q, et al. Adv Sci (Weinh). 2024 Apr;11(15):e2304203. doi: 10.1002/advs.202304203. Epub 2024 Feb 11. Adv Sci (Weinh). 2024. PMID: 38342610 Free PMC article.

62

Prognosis of uterine and extrauterine low-grade endometrial stromal sarcoma: an observational cohort study.

Dai Q, Xu B, Wu H, You Y, Li L. Dai Q, et al. Int J Surg. 2024 Apr 1;110(4):1919-1928. doi: 10.1097/JS9.0000000000001146. Int J Surg. 2024. PMID: 38329091 Free PMC article.

63

Endometrioid adenocarcinoma caused by adenomyosis: A case report.

Chen YH, Zhou Y, Xue M, Sun L. Chen YH, et al. Asian J Surg. 2024 Apr;47(4):1921-1922. doi: 10.1016/j.asjsur.2023.11.091. Epub 2024 Jan 23. Asian J Surg. 2024. PMID: 38262788 Free article. No abstract available.

64

Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety.

Buderath P, Elgharib M, Kimmig R. Buderath P, et al. Arch Gynecol Obstet. 2024 Apr;309(4):1569-1574. doi: 10.1007/s00404-023-07275-3. Epub 2024 Jan 13. Arch Gynecol Obstet. 2024. PMID: 38217762 Free PMC article.

65

HMGB1-mediated transcriptional activation of circadian gene TIMELESS contributes to endometrial cancer progression through Wnt-β-catenin pathway.

Wang Z, He S, Xin L, Zhou Y, Zhao L, Wang F. Wang Z, et al. Cell Signal. 2024 Apr;116:111045. doi: 10.1016/j.cellsig.2024.111045. Epub 2024 Jan 10. Cell Signal. 2024. PMID: 38211843 Free article.

66

Tumor-free strategies during total laparoscopic hysterectomy for a woman with early-stage high-risk endometrial cancer.

Sun HY, Zhao W, Zhao XW, Kang S. Sun HY, et al. Asian J Surg. 2024 Apr;47(4):1843-1844. doi: 10.1016/j.asjsur.2023.12.180. Epub 2024 Jan 5. Asian J Surg. 2024. PMID: 38182514 Free article. No abstract available.

67

Special Considerations in Classification and Workup of Endometrial Carcinomas.

Rottmann DA, Skala SL. Rottmann DA, et al. Arch Pathol Lab Med. 2024 Apr 1;148(4):390-397. doi: 10.5858/arpa.2023-0098-RA. Arch Pathol Lab Med. 2024. PMID: 37931213 Free article.

68

High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer.

Guo J, Tang B, Fu J, Zhu X, Xie W, Wang N, Ding Z, Song Z, Yang Y, Xu G, Xiao X. Guo J, et al. Cell Oncol (Dordr). 2024 Apr;47(2):573-585. doi: 10.1007/s13402-023-00885-8. Epub 2023 Oct 17. Cell Oncol (Dordr). 2024. PMID: 37847338 Free PMC article.

69

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.

Pla-Juher H, Pardo M, Izquierdo ÀJ, Darder E, Carbó A, Munté E, Torres-Esquius S, Balmaña J, Lázaro C, Brunet JM, Barretina-Ginesta MP. Pla-Juher H, et al. Clin Transl Oncol. 2024 Apr;26(4):1033-1037. doi: 10.1007/s12094-023-03312-4. Epub 2023 Sep 8. Clin Transl Oncol. 2024. PMID: 37682500 Free PMC article.

70

Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study.

Kong Y, Liu S, Wang X, Qie R. Kong Y, et al. Medicine (Baltimore). 2024 Mar 29;103(13):e37628. doi: 10.1097/MD.0000000000037628. Medicine (Baltimore). 2024. PMID: 38552081 Free PMC article.

71

Single-cell transcriptomics reveals comprehensive microenvironment and highlights the dysfuntional state of NK cells in endometrioid carcinoma.

Shi W, Wu W, Wang J, Meng X. Shi W, et al. Medicine (Baltimore). 2024 Mar 29;103(13):e37555. doi: 10.1097/MD.0000000000037555. Medicine (Baltimore). 2024. PMID: 38552055 Free PMC article.

72

Progesterone inhibits endometrial cancer growth by inhibiting glutamine metabolism through ASCT2.

Guo J, Fan J, Zhang Y, Li M, Jin Z, Shang Y, Zhang H, Kong Y. Guo J, et al. Biosci Rep. 2024 Mar 29;44(3):BSR20232035. doi: 10.1042/BSR20232035. Biosci Rep. 2024. PMID: 38415405 Free PMC article.

73

Knowledge Mapping of Cowden Syndrome: a Bibliometric Analysis.

Peng Q, Duan N, Wang X, Wang WM. Peng Q, et al. Chin J Dent Res. 2024 Mar 28;27(1):75-82. doi: 10.3290/j.cjdr.b5136733. Chin J Dent Res. 2024. PMID: 38546522 Free article. Review.

74

Analysis of the Expression of LSF Transcription Factor in the Regulation of Transcription and TSG101 during the Neoplastic Transformation of Endometrial Cells.

Ziemiński R, Stupak A, Kwiatek M, Gęca T, Warowicka A, Hejne K, Kwaśniewska A, Goździcka-Józefiak A, Kwaśniewski W. Ziemiński R, et al. Cells. 2024 Mar 26;13(7):580. doi: 10.3390/cells13070580. Cells. 2024. PMID: 38607019 Free PMC article.

75

Rel Family Transcription Factor NFAT5 Upregulates COX2 via HIF-1α Activity in Ishikawa and HEC1a Cells.

Okumura T, Raja Xavier JP, Pasternak J, Yang Z, Hang C, Nosirov B, Singh Y, Admard J, Brucker SY, Kommoss S, Takeda S, Staebler A, Lang F, Salker MS. Okumura T, et al. Int J Mol Sci. 2024 Mar 25;25(7):3666. doi: 10.3390/ijms25073666. Int J Mol Sci. 2024. PMID: 38612478 Free PMC article.

76

Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.

Alwafai Z, Beck MH, Fazeli S, Gürtler K, Kunz C, Singhartinger J, Trojnarska D, Zocholl D, Krankenberg DJ, Blohmer JU, Sehouli J, Pietzner K. Alwafai Z, et al. BMC Cancer. 2024 Mar 25;24(1):380. doi: 10.1186/s12885-024-12127-7. BMC Cancer. 2024. PMID: 38528468 Free PMC article.

77

Single-cell analysis reveals landscape of endometrial cancer response to estrogen and identification of early diagnostic markers.

Dong C, Zhao L, Liu X, Dang L, Zhang X. Dong C, et al. PLoS One. 2024 Mar 22;19(3):e0301128. doi: 10.1371/journal.pone.0301128. eCollection 2024. PLoS One. 2024. PMID: 38517922 Free PMC article.

78

Expression of E-Cadherin and N-Cadherin in the Endocervix as a Predictive Factor in Patients with Endometrial Cancer.

Frąszczak K, Barczyński B, Tylus B, Bednarek W. Frąszczak K, et al. Int J Mol Sci. 2024 Mar 21;25(6):3547. doi: 10.3390/ijms25063547. Int J Mol Sci. 2024. PMID: 38542521 Free PMC article.

79

Can MRI Accurately Diagnose and Stage Endometrial Adenocarcinoma?

Rizescu RA, Sălcianu IA, Șerbănoiu A, Ion RT, Florescu LM, Gheonea IA, Iana G, Bratu AM. Rizescu RA, et al. Medicina (Kaunas). 2024 Mar 21;60(3):512. doi: 10.3390/medicina60030512. Medicina (Kaunas). 2024. PMID: 38541238 Free PMC article.

80

Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.

Kuang L, Zhang J, Li Y, Wang Q, Liu J, Zhang B. Kuang L, et al. BMC Womens Health. 2024 Mar 21;24(1):188. doi: 10.1186/s12905-024-03021-2. BMC Womens Health. 2024. PMID: 38515066 Free PMC article.

81

Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real world.

Zhang K, Wang T, Liu Z, He J, Sun X, Zhong W, Zhao F, Li X, Li S, Zhu H, Ma Z, Hu K, Zhang F, Hou X, Wei L, Zou L. Zhang K, et al. BMC Cancer. 2024 Mar 20;24(1):360. doi: 10.1186/s12885-024-12090-3. BMC Cancer. 2024. PMID: 38509492 Free PMC article.

82

A comparative study of mono-exponential and advanced diffusion-weighted imaging in differentiating stage IA endometrial carcinoma from benign endometrial lesions.

Li HJ, Cao K, Li XT, Zhu HT, Zhao B, Gao M, Song X, Sun YS. Li HJ, et al. J Cancer Res Clin Oncol. 2024 Mar 20;150(3):141. doi: 10.1007/s00432-024-05668-8. J Cancer Res Clin Oncol. 2024. PMID: 38504026 Free PMC article.

83

Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study.

Sulaiman R, Dale A, Lin X, Aske JC, Gaster K, Starks D, Espaillat LR, De P, Dey N. Sulaiman R, et al. Int J Mol Sci. 2024 Mar 19;25(6):3441. doi: 10.3390/ijms25063441. Int J Mol Sci. 2024. PMID: 38542414 Free PMC article.

84

Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis.

Liang KW, Chen LJ, Wang CH, Ma KS, Hsia LH, Wang PH. Liang KW, et al. Front Immunol. 2024 Mar 18;15:1331994. doi: 10.3389/fimmu.2024.1331994. eCollection 2024. Front Immunol. 2024. PMID: 38562939 Free PMC article.

85

MicroRNA Expression in Endometrial Cancer: Current Knowledge and Therapeutic Implications.

Iavarone I, Molitierno R, Fumiento P, Vastarella MG, Napolitano S, Vietri MT, De Franciscis P, Ronsini C. Iavarone I, et al. Medicina (Kaunas). 2024 Mar 15;60(3):486. doi: 10.3390/medicina60030486. Medicina (Kaunas). 2024. PMID: 38541212 Free PMC article.

86

The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.

Li N, Chen Q, Li B. Li N, et al. Medicine (Baltimore). 2024 Mar 15;103(11):e37465. doi: 10.1097/MD.0000000000037465. Medicine (Baltimore). 2024. PMID: 38489719 Free PMC article.

87

Absolute Quantification of Selected microRNAs Expression in Endometrial Cancer by Digital PCR.

Bogaczyk A, Potocka N, Paszek S, Skrzypa M, Zuchowska A, Kośny M, Kluz M, Zawlik I, Kluz T. Bogaczyk A, et al. Int J Mol Sci. 2024 Mar 14;25(6):3286. doi: 10.3390/ijms25063286. Int J Mol Sci. 2024. PMID: 38542261 Free PMC article.

88

A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.

Sun Y, Zhang K, Wang T, Zhao S, Gao C, Xue F, Wang Y. Sun Y, et al. Sci Rep. 2024 Mar 13;14(1):6134. doi: 10.1038/s41598-024-56676-0. Sci Rep. 2024. PMID: 38480789 Free PMC article.

89

An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB-III uterine serous carcinoma.

Li S, Yi Z, Li M, Zhu Z. Li S, et al. Sci Rep. 2024 Mar 11;14(1):5884. doi: 10.1038/s41598-024-53172-3. Sci Rep. 2024. PMID: 38467644 Free PMC article.

90

Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer.

Hu D, Du J, Cheng Y, Xing Y, He R, Liang X, Li H, Yang Y. Hu D, et al. Biomol Biomed. 2024 Mar 11;24(2):346-359. doi: 10.17305/bb.2023.9489. Biomol Biomed. 2024. PMID: 37688492 Free PMC article.

91

Establishment of an immunogenic cell death-related model for prognostic prediction and identification of therapeutic targets in endometrial carcinoma.

Liu Z, Huang Y, Zhang P, Yang C, Wang Y, Yu Y, Xiang H. Liu Z, et al. Aging (Albany NY). 2024 Mar 8;16(5):4920-4942. doi: 10.18632/aging.205647. Epub 2024 Mar 8. Aging (Albany NY). 2024. PMID: 38461430 Free PMC article.

92

CD146⁺CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10/JAK1/STAT3 pathway.

Yu Z, Zhang Q, Wei S, Zhang Y, Zhou T, Zhang Q, Shi R, Zinovkin D, Pranjol ZI, Zhang J, Wang H. Yu Z, et al. Cell Commun Signal. 2024 Mar 8;22(1):170. doi: 10.1186/s12964-024-01550-9. Cell Commun Signal. 2024. PMID: 38459564 Free PMC article.

93

Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review.

Etrusco A, Laganà AS, Chiantera V, Mikuš M, Arsalan HM, d'Amati A, Vitagliano A, Cicinelli E, Favilli A, D'Amato A. Etrusco A, et al. Biomolecules. 2024 Mar 5;14(3):306. doi: 10.3390/biom14030306. Biomolecules. 2024. PMID: 38540726 Free PMC article. Review.

94

Lymph Node Isolated Tumor Cells in Patients With Endometrial Cancer.

Matsuo K, Chen L, Neuman MK, Klar M, Carlson JW, Roman LD, Wright JD. Matsuo K, et al. JAMA Netw Open. 2024 Mar 4;7(3):e240988. doi: 10.1001/jamanetworkopen.2024.0988. JAMA Netw Open. 2024. PMID: 38497964 Free PMC article.

95

DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway.

Xie S, Jin Y, Wang J, Li J, Peng M, Zhu X. Xie S, et al. BMC Cancer. 2024 Mar 4;24(1):296. doi: 10.1186/s12885-024-12030-1. BMC Cancer. 2024. PMID: 38438882 Free PMC article.

96

High TPX2 expression results in poor prognosis, and Sp1 mediates the coupling of the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt pathway through targeted inhibition of TPX2 in endometrial cancer.

Yang M, Mao X, Li L, Yang J, Xing H, Jiang C. Yang M, et al. Cancer Med. 2024 Mar;13(5):e6958. doi: 10.1002/cam4.6958. Cancer Med. 2024. PMID: 38466034 Free PMC article.

97

Psychometric validation of the Functional Assessment of Cancer Therapy-Endometrial among endometrial cancer patients.

Kim S, Noh JJ, Kim Y, Cho J, Kang D, Lee YY. Kim S, et al. Cancer Med. 2024 Mar;13(5):e7096. doi: 10.1002/cam4.7096. Cancer Med. 2024. PMID: 38466031 Free PMC article.

98

Study Protocol for the Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence (SISTER) study: a community engaged national randomized trial.

Oluloro A, Comstock B, Monsell SE, Gross M, Wolff EM, Sage L, Alson J, Lavallee DC, Hempstead B, Moore A, Katz R, Doll KM. Oluloro A, et al. J Comp Eff Res. 2024 Mar;13(3):e230159. doi: 10.57264/cer-2023-0159. Epub 2024 Feb 13. J Comp Eff Res. 2024. PMID: 38348827 Free PMC article.

99

Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia.

Levin G, Matanes E, Brezinov Y, Ferenczy A, Pelmus M, Brodeur MN, Salvador S, Lau S, Gotlieb WH. Levin G, et al. Eur J Surg Oncol. 2024 Mar;50(3):108006. doi: 10.1016/j.ejso.2024.108006. Epub 2024 Feb 7. Eur J Surg Oncol. 2024. PMID: 38342041 Free article.

100

Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.

Bjørnholt SM, Mogensen O, Bouchelouche K, Sponholtz SE, Parner ET, Hildebrandt MG, Loft A, Neumann G, Bjørn SF, Dahl K, Markauskas A, Frøding LP, Jensen PT. Bjørnholt SM, et al. Gynecol Oncol. 2024 Mar;182:179-187. doi: 10.1016/j.ygyno.2024.01.049. Epub 2024 Feb 9. Gynecol Oncol. 2024. PMID: 38335900 Free article.

101

Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.

Shim SH, Lee JY, Lee YY, Park JY, Lee YJ, Kim SI, Han GH, Yang EJ, Noh JJ, Yim GW, Son JH, Kim NK, Kim TH, Kong TW, Choi YJ, Cho A, Lim H, Jang EB, Cho HW, Suh DH. Shim SH, et al. J Gynecol Oncol. 2024 Mar;35(2):e66. doi: 10.3802/jgo.2024.35.e66. Epub 2024 Jan 25. J Gynecol Oncol. 2024. PMID: 38330382 Free PMC article.

102

Genome-wide association study identifies genetic regulation of oestrone concentrations and association with endometrial cancer risk in postmenopausal women.

Yu C, Bakshi A, Bell RJ, Islam RM, Handelsman DJ, McNeil JJ, Lacaze P, Davis SR. Yu C, et al. EBioMedicine. 2024 Mar;101:104997. doi: 10.1016/j.ebiom.2024.104997. Epub 2024 Feb 6. EBioMedicine. 2024. PMID: 38324981 Free PMC article.

103

Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

Yonemori K, Fujiwara K, Hasegawa K, Yunokawa M, Ushijima K, Suzuki S, Shikama A, Minobe S, Usami T, Kim JW, Kim BG, Wang PH, Chang TC, Yamamoto K, Han S, McKenzie J, Orlowski RJ, Miura T, Makker V, Man Kim Y. Yonemori K, et al. J Gynecol Oncol. 2024 Mar;35(2):e40. doi: 10.3802/jgo.2024.35.e40. Epub 2024 Jan 19. J Gynecol Oncol. 2024. PMID: 38302725 Free PMC article. Clinical Trial.

104

The BHLHE40‒PPM1F‒AMPK pathway regulates energy metabolism and is associated with the aggressiveness of endometrial cancer.

Asanoma K, Yagi H, Onoyama I, Cui L, Hori E, Kawakami M, Maenohara S, Hachisuga K, Tomonobe H, Kodama K, Yasunaga M, Ohgami T, Okugawa K, Yahata H, Kitao H, Kato K. Asanoma K, et al. J Biol Chem. 2024 Mar;300(3):105695. doi: 10.1016/j.jbc.2024.105695. Epub 2024 Jan 30. J Biol Chem. 2024. PMID: 38301894 Free PMC article.

105

Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.

Inoue F, Sone K, Kumegawa K, Hachijo R, Suzuki E, Tanimoto S, Tsuboyama N, Kato K, Toyohara Y, Takahashi Y, Kusakabe M, Kukita A, Honjoh H, Nishijima A, Taguchi A, Miyamoto Y, Tanikawa M, Iriyama T, Mori M, Wada-Hiraike O, Oda K, Suzuki H, Maruyama R, Osuga Y. Inoue F, et al. Int J Oncol. 2024 Mar;64(3):32. doi: 10.3892/ijo.2024.5620. Epub 2024 Feb 1. Int J Oncol. 2024. PMID: 38299254 Free PMC article.

106

Sentinel lymph node biopsy with carbon dye in endometrial cancer: a single center, prospective cohort study.

Minareci Y, Sozen H, Altinkara Hacioglu B, Yuvanc HO, Topuz S, Salihoglu MY. Minareci Y, et al. Surg Endosc. 2024 Mar;38(3):1608-1616. doi: 10.1007/s00464-023-10662-1. Epub 2024 Jan 30. Surg Endosc. 2024. PMID: 38291161 Free PMC article.

107

Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy.

Tubridy EA, Taunk NK, Ko EM. Tubridy EA, et al. Curr Treat Options Oncol. 2024 Mar;25(3):330-345. doi: 10.1007/s11864-023-01169-x. Epub 2024 Jan 4. Curr Treat Options Oncol. 2024. PMID: 38270800 Free PMC article. Review.

108

Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification.

Villiger AS, Zurbriggen S, Imboden S, Solass W, Christe L, Saner FAM, Gmür A, Rau TT, Mueller MD, Siegenthaler F. Villiger AS, et al. Gynecol Oncol. 2024 Mar;182:148-155. doi: 10.1016/j.ygyno.2024.01.006. Epub 2024 Jan 23. Gynecol Oncol. 2024. PMID: 38266401 Free article.

109

Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.

Casanova J, Duarte GS, da Costa AG, Catarino A, Nave M, Antunes T, Serra SS, Dias SS, Abu-Rustum N, Lima J. Casanova J, et al. Gynecol Oncol. 2024 Mar;182:99-107. doi: 10.1016/j.ygyno.2024.01.018. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262245 Free article. Review.

110

Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.

Recio F, Scalise CB, Loar P, Lumish M, Berman T, Peddada A, Kalashnikova E, Rivero-Hinojosa S, Beisch T, Nicosia B, Farmer T, Dutta P, Malhotra M, ElNaggar AC, Liu MC, Vaccarello L, Holloway RW. Recio F, et al. Gynecol Oncol. 2024 Mar;182:63-69. doi: 10.1016/j.ygyno.2023.12.025. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262240 Free article.

111

Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.

Xie H, Li M, Zheng Y. Xie H, et al. Gynecol Oncol. 2024 Mar;182:15-23. doi: 10.1016/j.ygyno.2024.01.007. Epub 2024 Jan 20. Gynecol Oncol. 2024. PMID: 38246042 Free article. Review.

112

Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement.

Kim JH, Kim DY, Kim J, Noh JJ, Hwang WY, Baek MH, Choi MC, Joo WD, Lee YJ, Suh DH, Kim YB. Kim JH, et al. J Gynecol Oncol. 2024 Mar;35(2):e45. doi: 10.3802/jgo.2024.35.e45. Epub 2024 Jan 5. J Gynecol Oncol. 2024. PMID: 38216137 Free PMC article. Review.

113

miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy.

Ravegnini G, Gorini F, Coada CA, De Leo A, de Biase D, Di Costanzo S, De Crescenzo E, Coschina E, Monesmith S, Bernante P, Garelli S, Balsamo F, Hrelia P, De Iaco P, Angelini S, Perrone AM. Ravegnini G, et al. Cancer Sci. 2024 Mar;115(3):883-893. doi: 10.1111/cas.15977. Epub 2024 Jan 9. Cancer Sci. 2024. PMID: 38196275 Free PMC article.

114

Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.

Kaya M, Post CCB, Tops CM, Nielsen M, Crosbie EJ, Leary A, Mileshkin LR, Han K, Bessette P, de Boer SM, Jürgenliemk-Schulz IM, Lutgens L, Jobsen JJ, Haverkort MAD, Nout RA, Kroep J, Creutzberg CL, Smit VTHBM, Horeweg N, van Wezel T, Bosse T. Kaya M, et al. Mod Pathol. 2024 Mar;37(3):100423. doi: 10.1016/j.modpat.2024.100423. Epub 2024 Jan 6. Mod Pathol. 2024. PMID: 38191122 Free article.

115

Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study.

de Jong A, Baeten IGT, Jansen A, Hoogendam JP, Jürgenliemk-Schulz IM, Zweemer RP, Gerestein CG. de Jong A, et al. J Minim Invasive Gynecol. 2024 Mar;31(3):243-249.e2. doi: 10.1016/j.jmig.2023.12.010. Epub 2024 Jan 1. J Minim Invasive Gynecol. 2024. PMID: 38171478 Free article.

116

Alternative-splicing regulator hnRNOs (heterogeneous nuclear ribonucleoproteins) family as a prognostic model associated with immune infiltration in endometrial cancer.

Chai Q, Sheng M, Tong H. Chai Q, et al. Asian J Surg. 2024 Mar;47(3):1665-1666. doi: 10.1016/j.asjsur.2023.12.061. Epub 2023 Dec 21. Asian J Surg. 2024. PMID: 38135538 Free article. No abstract available.

117

A Complex Interplay between Notch Effectors and β-Catenin Signaling in Morular Differentiation of Endometrial Carcinoma Cells.

Yokoi A, Murayama A, Hashimura M, Oguri Y, Harada Y, Fukagawa N, Hayashi M, Ono M, Ohhigata K, Saegusa M. Yokoi A, et al. Am J Pathol. 2024 Mar;194(3):459-470. doi: 10.1016/j.ajpath.2023.11.014. Epub 2023 Dec 12. Am J Pathol. 2024. PMID: 38096983 Free article.

118

LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1.

Huang Z, Shen F, Chen J, Xie B, Chen X, Zhao Y, Chen S. Huang Z, et al. J Gynecol Oncol. 2024 Mar;35(2):e21. doi: 10.3802/jgo.2024.35.e21. Epub 2023 Nov 21. J Gynecol Oncol. 2024. PMID: 38072399 Free PMC article.

119

Adjuvant carboplatin and paclitaxel with "sandwich" method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution.

Chinnadurai A, Breadner D, Baloush Z, Lohmann AE, Black M, D'Souza D, Welch S. Chinnadurai A, et al. J Gynecol Oncol. 2024 Mar;35(2):e16. doi: 10.3802/jgo.2024.35.e16. Epub 2023 Oct 16. J Gynecol Oncol. 2024. PMID: 37921600 Free PMC article.

120

PET/MRI in Endometrial Cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival.

Shih IL, Yen RF, Chen CA, Cheng WF, Chen BB, Zheng QY, Cheng MF, Chen JL, Shih TT. Shih IL, et al. Acad Radiol. 2024 Mar;31(3):939-950. doi: 10.1016/j.acra.2023.08.012. Epub 2023 Sep 14. Acad Radiol. 2024. PMID: 37714718 Free article.

121

DNA methylation of selected tumor suppressor genes in endometrial hyperplasia.

Dvorak O, Ndukwe M, Slavickova M, Laco J, Spacek J. Dvorak O, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Mar;168(1):68-73. doi: 10.5507/bp.2022.053. Epub 2023 Jan 9. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024. PMID: 36628559 Free article.

122

Thyroid Gland Metastasis From Endometrial Carcinoma Causing Acute Severe Dyspnea.

Bertone F, Serusi E, Liscia DS, Biletta E, Gervasio CF. Bertone F, et al. Ear Nose Throat J. 2024 Mar;103(3):NP142-NP144. doi: 10.1177/01455613211045564. Epub 2021 Sep 24. Ear Nose Throat J. 2024. PMID: 34558343 Free article.

123

Endometrial Sarcoma Metastasis to the Pterygopalatine Fossa: A Case Report and Review of the Literature.

Austell PJ, Levinson JS, Plitt MA, Ghai R, Gattuso P, Rupcich CR, Tajudeen BA. Austell PJ, et al. Ear Nose Throat J. 2024 Mar;103(3):148-150. doi: 10.1177/0145561320983943. Epub 2021 Jan 8. Ear Nose Throat J. 2024. PMID: 33415993 Free article. Review.

124

Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.

Henderson I, Black N, Khattak H; UKARCOG Working Group Authors; Gupta JK, Rimmer MP. Henderson I, et al. PLoS Med. 2024 Feb 29;21(2):e1004346. doi: 10.1371/journal.pmed.1004346. eCollection 2024 Feb. PLoS Med. 2024. PMID: 38421942 Free PMC article.

125

Polyphenols Influence the Development of Endometrial Cancer by Modulating the Gut Microbiota.

Baranowska-Wójcik E, Winiarska-Mieczan A, Olcha P, Kwiecień M, Jachimowicz-Rogowska K, Nowakowski Ł, Miturski A, Gałczyński K. Baranowska-Wójcik E, et al. Nutrients. 2024 Feb 28;16(5):681. doi: 10.3390/nu16050681. Nutrients. 2024. PMID: 38474808 Free PMC article. Review.

126

Lenvatinib plus Pembrolizumab Combination Therapy for Advanced or Recurrent Endometrial Cancer: A Single-Center, Retrospective Analysis.

Tochigi M, Shigeta S, Shimada M, Miyahara S, Hasegawa-Minato J, Shibuya Y, Ishibashi M, Hashimoto C, Tokunaga H, Yaegashi N. Tochigi M, et al. Tohoku J Exp Med. 2024 Feb 27;262(2):85-95. doi: 10.1620/tjem.2023.J095. Epub 2023 Nov 23. Tohoku J Exp Med. 2024. PMID: 38008437 Free article.

127

Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.

Stan A, Bosart K, Kaur M, Vo M, Escorcia W, Yoder RJ, Bouley RA, Petreaca RC. Stan A, et al. PLoS One. 2024 Feb 26;19(2):e0299114. doi: 10.1371/journal.pone.0299114. eCollection 2024. PLoS One. 2024. PMID: 38408048 Free PMC article.

128

Analysis of Characteristics of Endometrial Carcinoma in Peri- and Postmenopausal Women with Abnormal Uterine Bleeding.

Yanli Y, Mei WT, Cong L. Yanli Y, et al. Biomed Res Int. 2024 Feb 24;2024:6509171. doi: 10.1155/2024/6509171. eCollection 2024. Biomed Res Int. 2024. PMID: 38435540 Free PMC article.

129

Atractylenolide II Suppresses Glycolysis and Induces Apoptosis by Blocking the PADI3-ERK Signaling Pathway in Endometrial Cancer Cells.

Tian S, Ren L, Liu C, Wang Z. Tian S, et al. Molecules. 2024 Feb 21;29(5):939. doi: 10.3390/molecules29050939. Molecules. 2024. PMID: 38474453 Free PMC article.

130

Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.

Zhang Q, Luo Y, Zhang S, Huang Q, Liu G. Zhang Q, et al. Sci Rep. 2024 Feb 21;14(1):4257. doi: 10.1038/s41598-024-54651-3. Sci Rep. 2024. PMID: 38383747 Free PMC article.

131

LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.

Yang Q, Lv Z, Wang M, Kong M, Zhong C, Gao K, Wan X. Yang Q, et al. J Exp Clin Cancer Res. 2024 Feb 21;43(1):54. doi: 10.1186/s13046-024-02979-z. J Exp Clin Cancer Res. 2024. PMID: 38383447 Free PMC article.

132

Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial.

Koeneman BJ, Schreibelt G, Gorris MAJ, Hins-de Bree S, Westdorp H, Ottevanger PB, de Vries IJM. Koeneman BJ, et al. Front Immunol. 2024 Feb 20;15:1368103. doi: 10.3389/fimmu.2024.1368103. eCollection 2024. Front Immunol. 2024. PMID: 38444861 Free PMC article. Clinical Trial.

133

SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.

Liao LX, Zhang M, Xu X, Zhang S, Guo YZ. Liao LX, et al. Front Biosci (Landmark Ed). 2024 Feb 20;29(2):69. doi: 10.31083/j.fbl2902069. Front Biosci (Landmark Ed). 2024. PMID: 38420826 Free article.

134

Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma.

Chen X, Guo Q, Chen X, Zheng W, Kang Y, Cao D. Chen X, et al. BMC Med Imaging. 2024 Feb 19;24(1):48. doi: 10.1186/s12880-024-01225-4. BMC Med Imaging. 2024. PMID: 38373912 Free PMC article.

135

Effect of 3D laparoscopy versus traditional laparotomy on serum tumor markers and coagulation function in patients with early-stage endometrial cancer.

Chen H, Xu D, Yu Y, Huang J, Zhou Q, Wang Q. Chen H, et al. Clinics (Sao Paulo). 2024 Feb 17;79:100337. doi: 10.1016/j.clinsp.2024.100337. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 38368841 Free PMC article.

136

A novel immune-related gene signature for diagnosis and potential immunotherapy of microsatellite stable endometrial carcinoma.

Xiao Y, Yu X, Wang Y, Song G, Liu M, Wang D, Wang H. Xiao Y, et al. Sci Rep. 2024 Feb 14;14(1):3738. doi: 10.1038/s41598-024-53338-z. Sci Rep. 2024. PMID: 38355782 Free PMC article.

137

Interaction between XRCC2 gene polymorphism and abdominal obesity on risk of endometrial carcinoma.

Tian W, Cao S, Zhang W, Quan C, Zhang M, Huang Y. Tian W, et al. Gynecol Endocrinol. 2024 Feb 12;40(1):2317270. doi: 10.1080/09513590.2024.2317270. Epub 2024 Mar 22. Gynecol Endocrinol. 2024. PMID: 38518807 Free article.

138

The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study.

Yang J, Qu X, Zheng AJ, Jiang F, Chang H, Zhang JR, Yan LJ, Ning P. Yang J, et al. Sci Rep. 2024 Feb 12;14(1):3478. doi: 10.1038/s41598-024-53926-z. Sci Rep. 2024. PMID: 38347022 Free PMC article.

139

Mismatch repair gene MSH6 correlates with the prognosis, immune status and immune checkpoint inhibitors response of endometrial cancer.

Zhou LZ, Xiao HQ, Chen J. Zhou LZ, et al. Front Immunol. 2024 Feb 8;15:1302797. doi: 10.3389/fimmu.2024.1302797. eCollection 2024. Front Immunol. 2024. PMID: 38390329 Free PMC article.

140

Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection.

Zhao Q, Wang M, Chen M. Zhao Q, et al. BMC Womens Health. 2024 Feb 7;24(1):101. doi: 10.1186/s12905-024-02911-9. BMC Womens Health. 2024. PMID: 38326803 Free PMC article.

141

ACSL1-Mediated Fatty Acid β-Oxidation Enhances Metastasis and Proliferation in Endometrial Cancer.

Zhou Y, Li Y, Chen G, Guo X, Gao X, Meng J, Xu Y, Zhou N, Zhang B, Zhou X. Zhou Y, et al. Front Biosci (Landmark Ed). 2024 Feb 6;29(2):66. doi: 10.31083/j.fbl2902066. Front Biosci (Landmark Ed). 2024. PMID: 38420815 Free article.

142

Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.

Ling ZN, Hong LL, Wu J, Ling ZQ. Ling ZN, et al. Sci Rep. 2024 Feb 6;14(1):3030. doi: 10.1038/s41598-024-53489-z. Sci Rep. 2024. PMID: 38321173 Free PMC article.

143

Global and regional trends in the incidence and mortality burden of endometrial cancer, 1990-2019: Updated results from the Global Burden of Disease Study, 2019.

Feng J, Lin R, Li H, Wang J, He H. Feng J, et al. Chin Med J (Engl). 2024 Feb 5;137(3):294-302. doi: 10.1097/CM9.0000000000002841. Epub 2023 Oct 24. Chin Med J (Engl). 2024. PMID: 37874032 Free PMC article.

144

The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.

Lin J, Liu L, Wang L, Ma N, Zhang K, Xie N, Yu H, Deng S, Sun Y. Lin J, et al. World J Surg Oncol. 2024 Feb 3;22(1):42. doi: 10.1186/s12957-024-03319-3. World J Surg Oncol. 2024. PMID: 38310233 Free PMC article. Review.

145

Prediction of complete regression in fertility-sparing patients with endometrial cancer and apical hyperplasia: the GLOBAL model in a large Chinese cohort.

Li X, Wang Y, Wang J, Fan Y, Wang J. Li X, et al. J Transl Med. 2024 Feb 2;22(1):127. doi: 10.1186/s12967-023-04671-w. J Transl Med. 2024. PMID: 38308352 Free PMC article.

146

Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.

Santoro A, Bragantini E, Castiglione F, Ganesan R, Matias-Guiu X, Frattini M, Gallotta V, Garcia P, Pattni Y, Tsiampali-Laprell J, Bisaro B, Barbareschi M, Zannoni GF; Collaborators (IT ESP UK, CH). Santoro A, et al. Pathologica. 2024 Feb;116(1):32-45. doi: 10.32074/1591-951X-926. Pathologica. 2024. PMID: 38482673 Free PMC article.

147

Total Effective Xenoestrogen Burden in Serum Samples and Risk of Endometrial Cancer in the Spanish Screenwide Case-Control Study.

Costas L, Frias-Gomez J, Peinado FM, Molina-Molina JM, Peremiquel-Trillas P, Paytubi S, Crous-Bou M, de Francisco J, Caño V, Benavente Y, Pelegrina B, Martínez JM, Pineda M, Brunet J, Matias-Guiu X, de Sanjosé S, Ponce J, Olea N, Alemany L, Fernández MF. Costas L, et al. Environ Health Perspect. 2024 Feb;132(2):27012. doi: 10.1289/EHP13202. Epub 2024 Feb 28. Environ Health Perspect. 2024. PMID: 38415615 Free PMC article.

148

Evaluating the Prognostic Factors and Survival Rates of Endometrial Cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.

Wannasin R, Thinkhamrop K, Kelly M, Likitdee N. Wannasin R, et al. Asian Pac J Cancer Prev. 2024 Feb 1;25(2):671-679. doi: 10.31557/APJCP.2024.25.2.671. Asian Pac J Cancer Prev. 2024. PMID: 38415555 Free PMC article.

149

Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial Cancer: Single-Center Experiences in a Middle-Income Country.

Chitapanarux N, Tharavichitkul E, Kittidachanan K, Muangwong P, Chakrabandhu S, Klunklin P, Onchan W, Jia-Mahasap B, Torapichattrakul P, Chitapanarux I. Chitapanarux N, et al. Asian Pac J Cancer Prev. 2024 Feb 1;25(2):485-494. doi: 10.31557/APJCP.2024.25.2.485. Asian Pac J Cancer Prev. 2024. PMID: 38415534 Free PMC article.

150

Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population.

Kang N, Zhang X, Wang Z, Dai Y, Lu S, Su W, Gai F, Zhu C, Shen D, Wang J. Kang N, et al. Pathol Res Pract. 2024 Feb;254:155152. doi: 10.1016/j.prp.2024.155152. Epub 2024 Jan 20. Pathol Res Pract. 2024. PMID: 38277742 Free article.

151

Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability.

Yamashita T, Itoh T, Asano T, Suina A, Nishimori M, Munakata S, Satoh H. Yamashita T, et al. Int J Clin Oncol. 2024 Feb;29(2):222-231. doi: 10.1007/s10147-023-02449-0. Epub 2024 Jan 5. Int J Clin Oncol. 2024. PMID: 38177623 Free PMC article.

152

MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.

Helderman NC, Andini KD, van Leerdam ME, van Hest LP, Hoekman DR, Ahadova A, Bajwa-Ten Broeke SW, Bosse T, van der Logt EMJ, Imhann F, Kloor M, Langers AMJ, Smit VTHBM, Terlouw D, van Wezel T, Morreau H, Nielsen M. Helderman NC, et al. J Mol Diagn. 2024 Feb;26(2):106-114. doi: 10.1016/j.jmoldx.2023.10.005. Epub 2023 Dec 5. J Mol Diagn. 2024. PMID: 38061582 Free article.

153

Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m⁵C modification of SLC7A11 mRNA.

Chen SJ, Zhang J, Zhou T, Rao SS, Li Q, Xiao LY, Wei ST, Zhang HF. Chen SJ, et al. Redox Biol. 2024 Feb;69:102975. doi: 10.1016/j.redox.2023.102975. Epub 2023 Nov 29. Redox Biol. 2024. PMID: 38042059 Free PMC article.

154

Robotic-assisted surgery in high-risk surgical patients with endometrial cancer.

Collins A, Jacob A, Moss E. Collins A, et al. Best Pract Res Clin Obstet Gynaecol. 2024 Feb;92:102421. doi: 10.1016/j.bpobgyn.2023.102421. Epub 2023 Nov 4. Best Pract Res Clin Obstet Gynaecol. 2024. PMID: 37980868 Free article. Review.

155

Real-world utilization of lenvatinib and pembrolizumab combination therapy for the treatment of endometrial cancer in the USA.

Wada K, Zhang J, Lee I, Wang Y, Near A, Prabhu VS. Wada K, et al. Future Oncol. 2024 Feb;20(5):257-267. doi: 10.2217/fon-2023-0058. Epub 2023 Oct 13. Future Oncol. 2024. PMID: 37828843 Free article.

156

Intrauterine manipulator during hysterectomy for endometrial cancer: a systematic review and meta-analysis of oncologic outcomes.

Zorzato PC, Uccella S, Biancotto G, Bosco M, Festi A, Franchi M, Garzon S. Zorzato PC, et al. Am J Obstet Gynecol. 2024 Feb;230(2):185-198.e4. doi: 10.1016/j.ajog.2023.09.004. Epub 2023 Sep 12. Am J Obstet Gynecol. 2024. PMID: 37704174 Free article. Review.

157

Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.

Zhang T, Huang X, Liu W, Ling X, Su Z, Huang M, Che S. Zhang T, et al. Diagn Pathol. 2024 Jan 31;19(1):25. doi: 10.1186/s13000-024-01447-8. Diagn Pathol. 2024. PMID: 38297350 Free PMC article.

158

Novel LncRNA LINC02936 Suppresses Ferroptosis and Promotes Tumor Progression by Interacting with SIX1/CP Axis in Endometrial Cancer.

Zhang Z, Li B, Wang Z, Yang L, Peng J, Wang H, Wang Y, Hong L. Zhang Z, et al. Int J Biol Sci. 2024 Jan 27;20(4):1356-1374. doi: 10.7150/ijbs.86256. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385087 Free PMC article.

159

Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.

Shah SM, Demidova EV, Ringenbach S, Faezov B, Andrake M, Gandhi A, Mur P, Viana-Errasti J, Xiu J, Swensen J, Valle L, Dunbrack RL Jr, Hall MJ, Arora S. Shah SM, et al. Cancer Res Commun. 2024 Jan 26;4(1):213-225. doi: 10.1158/2767-9764.CRC-23-0312. Epub 2024 Jan 8. Cancer Res Commun. 2024. PMID: 38282550 Free PMC article.

160

Enhanced Diagnostic Efficiency of Endometrial Carcinogenesis and Progression in Women with Abnormal Uterine Bleeding through Peripheral Blood Cytokine Testing: A Multicenter Retrospective Cohort Study.

Ma J, Liu D, Mao X, Huang L, Ren Y, Xu X, Huang X, Deng C, Shi F, Sun P. Ma J, et al. Int J Med Sci. 2024 Jan 21;21(4):601-611. doi: 10.7150/ijms.91506. eCollection 2024. Int J Med Sci. 2024. PMID: 38464838 Free PMC article.

161

[A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].

Yao Y, Liu J, Zhou X, Liu Z, Qiu S, He Y, Zhou X. Yao Y, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jan 20;44(1):70-82. doi: 10.12122/j.issn.1673-4254.2024.01.09. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 38293978 Free PMC article. Chinese.

162

EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.

Joseph R, Dasari SK, Umamaheswaran S, Mangala LS, Bayraktar E, Rodriguez-Aguayo C, Wu Y, Nguyen N, Powell RT, Sobieski M, Liu Y, Kim MS, Corvigno S, Foster K, Hanjra P, Vu TC, Chowdhury MA, Amero P, Stephan C, Lopez-Berestein G, Westin SN, Sood AK. Joseph R, et al. Int J Mol Sci. 2024 Jan 20;25(2):1278. doi: 10.3390/ijms25021278. Int J Mol Sci. 2024. PMID: 38279277 Free PMC article.

163

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.

164

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.

Makker V, Taylor MH, Aghajanian C, Cohn AL, Brose MS, Simone CD, Cao ZA, Suttner L, Loboda A, Cristescu R, Jelinic P, Orlowski R, Dutta L, Matsui J, Dutcus CE, Minoshima Y, Messing MJ. Makker V, et al. J Immunother Cancer. 2024 Jan 19;12(1):e007929. doi: 10.1136/jitc-2023-007929. J Immunother Cancer. 2024. PMID: 38242717 Free PMC article.

165

The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway.

Tang M, Yin S, Zeng H, Huang A, Huang Y, Hu Z, Shah AR, Zhang S, Li H, Chen G. Tang M, et al. Cell Death Dis. 2024 Jan 18;15(1):69. doi: 10.1038/s41419-023-06418-3. Cell Death Dis. 2024. PMID: 38238314 Free PMC article.

166

Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer.

Ding Y, Lv Z, Cao W, Shi W, He Q, Gao K. Ding Y, et al. Cell Death Dis. 2024 Jan 17;15(1):65. doi: 10.1038/s41419-024-06431-0. Cell Death Dis. 2024. PMID: 38233384 Free PMC article.

167

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.

Wang G, Fu J, Liu M, Zheng Q. Wang G, et al. PLoS One. 2024 Jan 17;19(1):e0277872. doi: 10.1371/journal.pone.0277872. eCollection 2024. PLoS One. 2024. PMID: 38232115 Free PMC article.

168

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.

Addante F, d'Amati A, Santoro A, Angelico G, Inzani F, Arciuolo D, Travaglino A, Raffone A, D'Alessandris N, Scaglione G, Valente M, Tinnirello G, Sfregola S, Padial Urtueta B, Piermattei A, Cianfrini F, Mulè A, Bragantini E, Zannoni GF. Addante F, et al. Int J Mol Sci. 2024 Jan 15;25(2):1056. doi: 10.3390/ijms25021056. Int J Mol Sci. 2024. PMID: 38256131 Free PMC article. Review.

169

Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway.

Lin HH, Zeng WH, Yang HK, Huang LS, Pan R, Lei NX. Lin HH, et al. BMC Womens Health. 2024 Jan 13;24(1):41. doi: 10.1186/s12905-023-02857-4. BMC Womens Health. 2024. PMID: 38218826 Free PMC article.

170

Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features.

Hotton J, Gauchotte G, Mougel R, Migliorini M, Lacomme S, Battaglia-Hsu SF, Agopiantz M. Hotton J, et al. Int J Mol Sci. 2024 Jan 12;25(2):954. doi: 10.3390/ijms25020954. Int J Mol Sci. 2024. PMID: 38256026 Free PMC article.

171

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

Fu B, Zhou M, Geng X, Jiang Y, Zeng H, Zhou X, Yu Z, Pan J, Zhu Y, Zheng H, Huang S, Gong Y, Huang D, Zhong Y. Fu B, et al. Aging (Albany NY). 2024 Jan 11;16(1):714-745. doi: 10.18632/aging.205414. Epub 2024 Jan 11. Aging (Albany NY). 2024. PMID: 38217544 Free PMC article.

172

Robotic-assisted surgery for endometrial cancer: a comparison of surgical and oncologic outcomes in patients with low and high BMI at an Indian tertiary care center.

Joshi R, Bora RR, Sonwani T. Joshi R, et al. J Robot Surg. 2024 Jan 11;18(1):7. doi: 10.1007/s11701-023-01747-z. J Robot Surg. 2024. PMID: 38206488 Free PMC article.

173

Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.

Reid K, Camacho-Vanegas O, Pandya D, Camacho SC, Qiao RF, Kalir T, Padron-Rhenals MM, Beddoe AM, Dottino P, Martignetti JA. Reid K, et al. Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4):a006311. doi: 10.1101/mcs.a006311. Print 2023 Dec. Cold Spring Harb Mol Case Stud. 2024. PMID: 37848227 Free PMC article.

174

RING1 Inhibition Has a Cell-Specific Antitumoral Role by Promoting Autophagy in Endometrial Cancer Cells.

Szustka A, Kozal K, Krześlak A. Szustka A, et al. Cell Physiol Biochem. 2024 Jan 8;58(1):1-13. doi: 10.33594/000000679. Cell Physiol Biochem. 2024. PMID: 38219048 Free article.

175

Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer.

Ueno Y, Yoshida E, Nojiri S, Kato T, Ohtsu T, Takeshita T, Suzuki S, Yoshida H, Kato K, Itoh M, Notomi T, Usui K, Sozu T, Terao Y, Kawaji H, Kato H. Ueno Y, et al. Jpn J Clin Oncol. 2024 Jan 7;54(1):38-46. doi: 10.1093/jjco/hyad135. Jpn J Clin Oncol. 2024. PMID: 37815156 Free PMC article.

176

Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia.

Wu P, Shan W, Xue Y, Wang L, Liu S, Chen X, Luo X. Wu P, et al. Front Endocrinol (Lausanne). 2024 Jan 5;14:1286724. doi: 10.3389/fendo.2023.1286724. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38250737 Free PMC article.

177

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.

Colombo N, Lorusso D, Monk BJ, Slomovitz B, Hasegawa K, Nogueira-Rodrigues A, Zale M, Okpara CE, Barresi G, McKenzie J, Makker V. Colombo N, et al. Oncologist. 2024 Jan 5;29(1):25-35. doi: 10.1093/oncolo/oyad201. Oncologist. 2024. PMID: 37523661 Free PMC article.

178

Endometrioid carcinomas with sex cord-like formations and hyalinization: spontaneous pregnancy after conservative treatment.

Gama Q, Luo S, Wu P, Wang L, Liu S, Zhang H, Sun L, Wang Y, Yu M, Chen X, Shan W, Luo X. Gama Q, et al. BMC Pregnancy Childbirth. 2024 Jan 4;24(1):30. doi: 10.1186/s12884-023-06219-8. BMC Pregnancy Childbirth. 2024. PMID: 38178060 Free PMC article.

179

Impact of surgical approach on progress of disease by type of histology in stage IA endometrial cancer: a matched-pair analysis.

Miao H, Zhang L, Jiang Y, Wan Y, Yuan L, Cheng W. Miao H, et al. BMC Surg. 2024 Jan 3;24(1):9. doi: 10.1186/s12893-023-02299-7. BMC Surg. 2024. PMID: 38172752 Free PMC article.

180

Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer.

Zheng S, Donnelly ED, Strauss JB. Zheng S, et al. JAMA Netw Open. 2024 Jan 2;7(1):e2351906. doi: 10.1001/jamanetworkopen.2023.51906. JAMA Netw Open. 2024. PMID: 38231514 Free PMC article.

181

Identification of hub genes distinguishing subtypes in endometrial stromal sarcoma through comprehensive bioinformatics analysis.

Zhang R, Zhao W, Zhu X, Liu Y, Ding Q, Yang C, Zou H. Zhang R, et al. Sci Rep. 2024 Jan 2;14(1):37. doi: 10.1038/s41598-023-47668-7. Sci Rep. 2024. PMID: 38167455 Free PMC article.

182

Prognostic factors of patients with recurrent uterine malignancies undergoing secondary cytoreductive surgery.

Fang C, Zhang Y, Zhang P, Zhu T. Fang C, et al. BMC Womens Health. 2024 Jan 2;24(1):9. doi: 10.1186/s12905-023-02708-2. BMC Womens Health. 2024. PMID: 38166810 Free PMC article.

183

Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.

Beddows I, Fan H, Heinze K, Johnson BK, Leonova A, Senz J, Djirackor S, Cho KR, Pearce CL, Huntsman DG, Anglesio MS, Shen H. Beddows I, et al. Cancer Res. 2024 Jan 2;84(1):26-38. doi: 10.1158/0008-5472.CAN-23-1362. Cancer Res. 2024. PMID: 37874327 Free PMC article.

184

Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.

Li H, Wang J, Zhang G, Li L, Shen Z, Zhai Z, Wang Z, Wang J. Li H, et al. Womens Health (Lond). 2024 Jan-Dec;20:17455057241248398. doi: 10.1177/17455057241248398. Womens Health (Lond). 2024. PMID: 38725247 Free PMC article.

185

Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.

Wang SF, Du CY, Li M, Wen B, Shen QJ, Ma F, Zhang L, Deng H. Wang SF, et al. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241242637. doi: 10.1177/15330338241242637. Technol Cancer Res Treat. 2024. PMID: 38584417 Free PMC article.

186

An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillance.

Lantsman T, Jansen C, Larson E, Esselen K, Shea M. Lantsman T, et al. Cancer Treat Res Commun. 2024;39:100812. doi: 10.1016/j.ctarc.2024.100812. Epub 2024 Apr 4. Cancer Treat Res Commun. 2024. PMID: 38582032 Free article.

187

Characteristics of patients with late recurrence endometrial cancer.

Çakır İ, Gülseren V, Özdemir İA, Abacı H, Talu ECK, Çakır ZE, Ata C, Kuru O, Gökçü M, Sancı M, Güngördük K. Çakır İ, et al. J Cancer Res Ther. 2024 Jan 1;20(1):232-237. doi: 10.4103/jcrt.jcrt_888_22. Epub 2023 Apr 8. J Cancer Res Ther. 2024. PMID: 38554326 Free article. Review.

188

Endometrial stromal tumors: A clinico-histomorphological spectrum of endometrial stromal tumors with review of literature.

Verma A, Tomar R, Chaturvedi A, Dhankar N, Mallya V, Khurana N. Verma A, et al. J Cancer Res Ther. 2024 Jan 1;20(1):150-155. doi: 10.4103/jcrt.jcrt_741_22. Epub 2023 Apr 7. J Cancer Res Ther. 2024. PMID: 38554313 Free article. Review.

189

Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden.

Ralph L, Young K, Upadhyay N, Prabhu VS, Ljungcrantz C, Massaad R, Xu R, Giertz A, Merchant A, Orlowski R, Duska L. Ralph L, et al. J Med Econ. 2024 Jan-Dec;27(1):483-491. doi: 10.1080/13696998.2024.2329022. Epub 2024 Mar 26. J Med Econ. 2024. PMID: 38470404 Free article.

190

Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.

Jassar A, Hemali N, Bhatnagar A. Jassar A, et al. Indian J Pathol Microbiol. 2024 Jan-Mar;67(1):68-73. doi: 10.4103/ijpm.ijpm_748_22. Indian J Pathol Microbiol. 2024. PMID: 38358191 Free article.

191

To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.

Yadav A, Sistla A, Swain M, Gowrishankar S, Padua M, Modi T, Himabindu R, Agarwal N, Kulkarni A, Bhandari T, Vudayaraju H, Chinnababu, Reddy VA. Yadav A, et al. Indian J Pathol Microbiol. 2024 Jan-Mar;67(1):62-67. doi: 10.4103/ijpm.ijpm_568_22. Indian J Pathol Microbiol. 2024. PMID: 38358190 Free article.

192

The Impact of Waiting Time-to-Surgery on Survival in Endometrial Cancer Patients.

Plubprasit J, Sukkasame P, Bhamarapravatana K, Suwannarurk K. Plubprasit J, et al. Asian Pac J Cancer Prev. 2024 Jan 1;25(1):95-101. doi: 10.31557/APJCP.2024.25.1.95. Asian Pac J Cancer Prev. 2024. PMID: 38285772 Free PMC article.

193

Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.

Papadopoulou E, Rigas G, Fountzilas E, Boutis A, Giassas S, Mitsimponas N, Daliani D, Ziogas DC, Liontos M, Ramfidis V, Christophilakis C, Matthaios D, Floros T, Florou-Chatzigiannidou C, Agiannitopoulos K, Meintani A, Tsantikidi A, Katseli A, Potska K, Tsaousis G, Metaxa-Mariatou V, Nasioulas G. Papadopoulou E, et al. JCO Precis Oncol. 2024 Jan;8:e2300332. doi: 10.1200/PO.23.00332. JCO Precis Oncol. 2024. PMID: 38271656 Free PMC article.

194

Endometrial Stem Cells: Orchestrating Dynamic Regeneration of Endometrium and Their Implications in Diverse Endometrial Disorders.

Hong IS. Hong IS. Int J Biol Sci. 2024 Jan 1;20(3):864-879. doi: 10.7150/ijbs.89795. eCollection 2024. Int J Biol Sci. 2024. PMID: 38250149 Free PMC article. Review.

195

The role of shear wave elastography in predicting endometrial cancer in patients presenting with abnormal uterine bleeding.

Guler AH, Ates MC, Avcı F, Seher N, Cintesun E, Bilgi A, Korez MK, Koplay M, Celik C. Guler AH, et al. Eur Rev Med Pharmacol Sci. 2024 Jan;28(1):365-372. doi: 10.26355/eurrev_202401_34925. Eur Rev Med Pharmacol Sci. 2024. PMID: 38235888 Free article.

196

Prediction of lymph node metastasis based on tumor size in stage 1A endometrioid endometrium cancer.

Avcı F, Can B, Dik B, Gulmez A, Kulhan M, Celik C, Bilgi A. Avcı F, et al. Eur Rev Med Pharmacol Sci. 2024 Jan;28(1):214-220. doi: 10.26355/eurrev_202401_34906. Eur Rev Med Pharmacol Sci. 2024. PMID: 38235872 Free article.

197

Para-aortic lymphadenectomy in endometrial cancer patients with left-sided inferior vena cava: A case report and literature review.

Higashi Y, Togami S, Kobayashi H. Higashi Y, et al. Taiwan J Obstet Gynecol. 2024 Jan;63(1):98-102. doi: 10.1016/j.tjog.2023.07.037. Taiwan J Obstet Gynecol. 2024. PMID: 38216280 Free article. Review.

198

Expected treatment for endometrial polyp.

Li YT, Yang ST, Wang PH. Li YT, et al. Taiwan J Obstet Gynecol. 2024 Jan;63(1):1-3. doi: 10.1016/j.tjog.2023.11.001. Taiwan J Obstet Gynecol. 2024. PMID: 38216241 Free article. No abstract available.

199

Nutritional index in relation to prognosis of endometrial cancer.

Gen Y, Yun J, Ahn J, Yoon JH, Park DC, Kim SI. Gen Y, et al. Int J Med Sci. 2024 Jan 1;21(1):169-174. doi: 10.7150/ijms.87752. eCollection 2024. Int J Med Sci. 2024. PMID: 38164359 Free PMC article.

200

EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.

Huang YH, Wang WL, Wang PH, Lee HT, Chang WW. Huang YH, et al. Int J Biol Sci. 2024 Jan 1;20(1):265-279. doi: 10.7150/ijbs.86275. eCollection 2024. Int J Biol Sci. 2024. PMID: 38164180 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,034 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,034 results

Results by year